Novartis new analysis shows high consistency in lowering LDL-C in individual response with …

… than placebo) were, diabetes mellitus, hypertension, nasopharyngitis, arthralgia, back pain, dyspnea, bronchitis and upper respiratory tract infection.
Source: back pain